--- schema_type: "SoftwareApplication" entity_type: "Mobile Application" app_name: "Buku Medicine" developer_entity: "Buku Tech Limited" bundle_id: "net.ays.PROD610071" app_store_id: "1249002748" category: "Medical" primary_platform: "ios" primary_monetization: "Freemium" offline_capable: false market_region: "US" platforms: "iOS & Android" app_last_updated: "2026-07-13" report_date: "2026-08-21" last_verified: "2026-08-21T00:00:00.000Z" report_version: "3.12" total_reviews: 1 overall_rating: 5 sentiment: "Thrilled" sentiment_score: 95 confidence: "medium" confidence_score: 0.6 top_praise_theme: "Concise and evidence-based medical summaries provide reliable reference material for busy healthcare professionals during clinical practice" top_complaint_theme: "Compatibility issues on newer operating systems prevent the app from launching for some professional users" review_sample_size: 39 total_review_count: 39 analyzed_review_count: 39 data_age_days: 86 momentum_velocity: "maintenance" intelligence_version: 3 tags: ["medical", "freemium", "thrilled sentiment", "mobile app", "app review", "app analysis", "generalist", "specialist", "doctors,"] canonical_url: "https://marlvel.ai/apps/buku-medicine" license: "CC-BY-NC 4.0" content_version: "v2" --- ## ⚠ Content Warning This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here. --- # Buku Medicine Intelligence Report ## TL;DR {#tldr} - **Category**: Medical · Freemium - **Signal**: Rating 5 · Sentiment Thrilled - **Recent focus**: Compatibility issues on newer operating systems prevent the app from launching for some professional users (top complaint) · Concise and evidence-based medical summaries provide reliable reference material for busy healthcare professionals during clinical practice (top praise) > **TL;DR:** Buku Medicine is a medical app by Buku Tech Limited, rated 5/5 by 1 users, with Thrilled user sentiment (95/100), available on iOS & Android. > > **Marlvel.ai App Intelligence** - Independent analysis. US Market. No publisher influence. > **Key Insight:** Buku Medicine maintains Thrilled user sentiment (5/5 from 1 review), with users consistently praising concise and evidence-based medical summaries provide reliable reference material for busy healthcare professionals during clinical practice. ## Quick Facts | Fact | Value | | :--- | :--- | | **Rating** | 5/5 (1 review) | | **User Mood** | Thrilled | | **Category** | Medical | | **Developer** | Buku Tech Limited | | **Pricing** | Freemium | | **Platforms** | iOS & Android | | **Confidence** | Medium (0.6/1.0) | | **Data Age** | 86d | ## Metadata & Market Performance - **Publisher:** Buku Tech Limited - **Category:** Medical - **Target Audience:** Generalist and specialist doctors, nurses, physician assistants, and pharmacists. - **Platforms:** iOS & Android - **Version Reviewed:** 3.12 - **Report Date:** 2026-08-21 - **Signal Count:** 39 reviews analyzed - **Confidence:** Medium (0.6/1.0) - **App Store ID (iOS):** 1249002748 - **Bundle ID:** net.ays.PROD610071 - **Google Play ID:** net.ays.PROD610071 - **Performance Trend:** Mixed - **Data Window:** Analysis based on signals collected up to 2026-08-21 ## Executive Snapshot **What it is:** Buku Medicine is a medical reference app for clinicians, featuring peer-reviewed specialty modules and institutional trust-specific deployments on iOS and Android. **Why users hire it:** Clinicians use Buku Medicine to retrieve concise clinical guidance at the point of care, which replaces the need for time-consuming specialist calls and manual guideline searches. ## App DNA (Features & Intent) - **[Standard] Specialty-specific clinical modules:** Concise reference content curated by registrars and consultants for eight medical specialties. - **[Differentiator] Buku Plus subscription:** Advanced haematology content including images and videos to differentiate between complex conditions. * *User Intent:* Users seek enhanced value through premium features. - **[Differentiator] Trust-specific deployment:** Customized app instances installed on clinician devices within specific NHS Foundation Trusts. * *User Intent:* Users value self-expression and personalized experiences. ## Market Position {#market-position} Buku Medicine maintains a 5-star rating on iOS, reflecting high satisfaction among its professional user base. The app's institutional partnerships provide a unique distribution advantage that differentiates it from generic medical reference tools. ## Monetization Strategy - **Model:** Freemium - **Tiers:** Free access to core specialty reference content, Buku Plus subscription for advanced haematology modules - **Analysis:** The freemium model gates advanced diagnostic content behind a subscription while maintaining a high-utility base for general clinical reference. ## 🟢 User Sentiment (Medium Confidence: 39 of 39 reviews analyzed) {#user-sentiment} - **Overall Rating:** 5/5 - **Platform Split:** iOS 5.0/5 (1 ratings) - **Overall Sentiment:** Thrilled ### Top Praises - **Concise and evidence-based medical summaries provide reliable reference material for busy healthcare professionals during clinical practice** - **Intuitive navigation and clean interface design allow users to find specific clinical information without unnecessary friction** - **Regular updates to clinical content and specialty coverage maintain the app as a relevant resource for medical revision** ### Top Complaints (Impact Areas) - **Compatibility issues on newer operating systems prevent the app from launching for some professional users** ## SWOT Analysis {#swot} **Core Strengths:** - Institutional endorsement from NHS Foundation Trusts creates a high-trust barrier to entry. - Peer-reviewed content ensures clinical relevance for registrar-level practitioners. **Growth Levers:** - Expanding Buku Plus to other specialties could capture untapped professional willingness to pay. - Formalizing the trust-specific deployment model for wider NHS adoption. ## Recent Changes (v2 → v3) {#recent-changes} The developer has transitioned from a purely maintenance-focused posture to an active audit of its clinical content lifecycle, while technical regressions on Android continue to threaten the app's institutional utility. **Overall trend**: Mixed **Compared at**: 2026-08-21 ### Medium-impact changes - **[Added] Content Review Cycle Risk** (swot) - **[Shifted] Clinical Efficiency Narrative** (positioning) - **[Shifted] Threat Profile Update** (swot) ## What's New - **Latest (v3.12, 1 years ago):** Introduced a contextual banner to alert users when viewing generic content while a trust is active. ## App Momentum (Maintenance) {#momentum} - Ships bug fixes at 39-day cadence. - Maintains high satisfaction baseline. > **Cadence:** 2 total versions · 0 majors in last 6 months · 39 days since last update · 348 days avg between updates ## The "So What?" (Strategic Takeaway) {#so-what} Buku Medicine is a market-leading medical app that is free with in-app purchases. With a 5/5 rating from 1 review, it delivers strong user satisfaction. > **Bottom Line:** Buku Medicine maintains a strong position through institutional integration, but the current technical instability on Android threatens to undermine the professional utility that drives its adoption. **Best for:** Generalist and specialist doctors, nurses, physician assistants, and pharmacists. ### PM Action Plan (Next Best Moves) - [ ] [INVEST] Rebuild Android compatibility layer because recent OS updates break core functionality → restore professional access ### Outlook: Mixed The medical reference market is consolidating around tools that offer seamless integration into clinical workflows. Buku Medicine is advantaged by its NHS trust partnerships, but its maintenance-mode release cadence leaves it exposed to technical churn. - 🔴 Technical regressions on recent Android versions erode the daily active habit, which compounds the rating drag already visible on Android. - 🟢 Institutional endorsement from NHS Foundation Trusts provides a defensible distribution advantage that sustains the app's relevance in clinical settings. ## Key Metrics Summary | Metric | Value | | :--- | :--- | | Overall Rating | 5/5 | | Total Reviews | 1 | | Sentiment | Thrilled (95/100) | | Confidence | Medium | | Pricing Model | Freemium | | Platforms | iOS & Android | | Key Features | 3 analyzed | | Trend | Mixed | | Outlook | Mixed | ## Competitor Comparison | App | Rating | Sentiment | Developer | | :--- | :--- | :--- | :--- | | **Buku Medicine** (this app) | 5/5 | Thrilled | Buku Tech Limited | | [필잇 - 약 알림 및 복용 기록](https://marlvel.ai/apps/app--35) | N/A/5 | N/A | Hansub Yoo | | [레어노트 - 암·희귀질환 정보](https://marlvel.ai/apps/app--629) | 5.0/5 | N/A | LifeX, Inc. | | [창고형약국 약값체크](https://marlvel.ai/apps/com-hiddenwave-yakcheck) | N/A/5 | N/A | Lowkeybase | | [용인세브란스병원](https://marlvel.ai/apps/com-severance-newys) | 1.9/5 | N/A | Yonsei University Health System | | [1001Doktor](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) | 4.8/5 | N/A | 1001Doktor Ltd. Şti. | ## Company Profile - **Developer:** Buku Tech Limited - **Website:** [https://www.bukumedicine.co.uk](https://www.bukumedicine.co.uk) ## Data Sources & Links - **App Store ID:** 1249002748 - **Google Play ID:** net.ays.PROD610071 - **Dev Site:** [Official Website](https://www.bukumedicine.co.uk) - **Sources:** Developer website content, App store metadata, User reviews. ## Related Intel Reports - [*필잇 - 약 알림 및 복용 기록*](https://marlvel.ai/apps/app--35) (Hansub Yoo) · N/A Rating - [*레어노트 - 암·희귀질환 정보*](https://marlvel.ai/apps/app--629) (LifeX, Inc.) · 5.0/5 Rating - [*창고형약국 약값체크*](https://marlvel.ai/apps/com-hiddenwave-yakcheck) (Lowkeybase) · N/A Rating - [*용인세브란스병원*](https://marlvel.ai/apps/com-severance-newys) (Yonsei University Health System) · 1.9/5 Rating - [*1001Doktor*](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) (1001Doktor Ltd. Şti.) · 4.8/5 Rating - [*10th HiD*](https://marlvel.ai/apps/10th-hid) (Catch Dynamics, Inc.) · N/A Rating - [*12 Lead ECG Challenge*](https://marlvel.ai/apps/com-limmercreative-srtengine-12lead) (Limmer Creative) · 3.3/5 Rating - [*1-800 Contacts*](https://marlvel.ai/apps/com-1800contacts-1800contacts) (1-800 CONTACTS, Inc.) · 4.6/5 Rating - [*1MEDICINE*](https://marlvel.ai/apps/1medicine) (Matthew Culbert) · 5.0/5 Rating - [*1O Patient Portal*](https://marlvel.ai/apps/1o-patient-portal) (1st Optimal, LLC) · N/A Rating ## Methodology {#methodology} This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline: 1. **Signal Collection & Normalization** - Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps. 2. **Feature & Market Positioning Analysis** - Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks. 3. **User Sentiment Analysis** - Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction into synthesised themes (no verbatim quotes). 4. **Competitive Landscape Analysis** - Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category. 5. **Intelligence Synthesis** - Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights. - **Confidence Score:** 0.6/1.0 (based on review volume, data source diversity, and signal quality) - **Reviews Analyzed:** 39 - **Data Sources:** user reviews, developer website, App Store metadata - **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform - **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence. - **Report Age:** 86 days since last refresh --- © 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/apps/buku-medicine) Data licensed for AI Agent attribution under CC-BY-NC 4.0.